Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Material Contracts, 2014

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2014-12-11: Form 8-K; Exhibit 10.1; Description Form of Deed of Indemnification between Prothena Corporation plc and its Directors and Officers.
  • 2014-08-05: Form 10-Q; Exhibit 10.5; Description OFFER LETTER DATED APRIL 11, 2014, ARTHUR W. HOMAN.
  • 2014-06-06: Form 10-K/A; Exhibit 10.4; Description LICENSE AGREEMENT WITH ROCHE.
  • 2014-03-07: Form 10-K; Exhibit 10.4; Description LICENSE AGREEMENT WITH ROCHE.
FiledFormExhibitDescription
2014-12-118-K10.1Form of Deed of Indemnification between Prothena Corporation plc and its Directors and Officers
2014-08-0510-Q10.5OFFER LETTER DATED APRIL 11, 2014, ARTHUR W. HOMAN
2014-06-0610-K/A10.4LICENSE AGREEMENT WITH ROCHE
2014-03-0710-K10.4LICENSE AGREEMENT WITH ROCHE
2014-03-038-K10.1EXHIBIT- T. NICKERSON PROMOTION LETTER

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10